SCHEMBL7733796

SCHEMBL7733796

COc1cc(N)ccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccc2[N+](=O)[O-])CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 7/20 0.57
ADRA1A P35348 6/20 0.57
DRD4 P21917 4/20 0.57
ADRA1B P35368 4/20 0.57
ADRA1D P25100 3/20 0.57
HTR7 P34969 2/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57
TSHR P16473 1/20 0.57
HTR1B P28222 1/20 0.57
HTR2B P41595 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.52
MEN1 O00255 1/20 0.52
LMNA P02545 1/20 0.52
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52
KMT2A Q03164 1/20 0.52
HTR2A P28223 1/20 0.44
DRD2 P14416 1/20 0.43
DRD3 P35462 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL989581 0.90 HTR1A (0.69) HTR1AADRA1ADRD4ADRA1BADRA1D
SCHEMBL7612682 0.90 HTR1A (0.56) HTR1AADRA1ADRD4ADRA1BADRA1D
SCHEMBL7736577 0.88 HTR1A (0.54) HTR1AADRA1ADRD4ADRA1BADRA1D
SCHEMBL7611697 0.88 HTR1A (0.54) HTR1AADRA1ADRD4ADRA1BADRA1D
SCHEMBL7607814 0.88 HTR1A (0.54) HTR1AADRA1ADRD4ADRA1BADRA1D
SCHEMBL6312809 0.87 HTR1A (0.64) HTR1AADRA1ADRD4ADRA1BADRA1D
SCHEMBL6312815 0.87 HTR1A (0.64) HTR1AADRA1ADRD4ADRA1BADRA1D
SCHEMBL7613972 0.85 HTR1A (0.57) HTR1AADRA1ADRD4ADRA1BADRA1D
SCHEMBL7608873 0.84 HTR1A (0.59) HTR1AADRA1ADRD4ADRA1BADRA1D
SCHEMBL7955093 0.83 HTR1A (0.81) HTR1AADRA1ADRD4ADRA1BADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399614-B1 TREATING NEUROMUSCULAR DYSFUNCTION OF LOWER URINARY TRACT VIA PERIPHERAL OR CENTRAL NERVOUS SYSTEM; SEROTONIN RECEPTOR ANTAGONIST RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY (CH) 2002-06-04 US disclosed